Daxxify (daxibotulinumtoxinA-lanm) Acetylcholine release inhibitor and neuromuscular blocking agent Treatment of cervical dystonia in adults. Daxxify Approved for Cervical Dystonia Treatment Ilaris ...

[Jerusalem, Israel ] - In a new study, a group of researchers, led by Dr. Joshua Goldberg from the Hebrew University, describe a new kind of neurochemical wave in the brain. Their research, published ...

More than 60% of complement inhibitor–naive patients with acetylcholine receptor–positive generalized myasthenia gravis (MG) in diverse clinical populations had a clinically meaningful reduction in MG ...

Credit: Hugel. Letybo, an acetylcholine release inhibitor and a neuromuscular blocking agent, was approved in March 2024 based on data from three phase 3 trials. Letybo should be administered no more ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved UCB’s Zilbrysq for the treatment of generalized myasthenia gravis in adults who are ...